IMPORTANT DISCLAIMER: Blank Capital Research ("BCR") is a technology platform, not a registered investment advisor or broker-dealer. The algorithmically generated signals, scores, and rankings provided on this site ("God Mode" Signals) are for informational and research purposes only and do not constitute financial advice, investment recommendations, or an offer to sell or solicit an offer to buy any securities.
HYPOTHETICAL PERFORMANCE RESULTS: The "timing scores" and "regime signals" displayed are based on quantitative models. Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading. Also, since the trades have not actually been executed, the results may have under-or-over compensated for the impact, if any, of certain market factors, such as lack of liquidity.
RISK OF LOSS: Trading in financial markets involves a high degree of risk and may result in the loss of your entire investment. Data provided by third-party sources (Intrinio, Snowflake) is believed to be reliable but is not guaranteed for accuracy or completeness. Past performance is not indicative of future results.
Relative valuation derived from Financials sector median benchmarks. Model weights: EV/EBITDA (40%), P/B (35%), P/S (25%). Multiples adjusted for extreme outliers and non-recurring volatility.
Auditing capital efficiency...
Quality Profile Audit
Score: 55.3GRADE C+
Composite assessment of profitability, capital efficiency, and financial strength. Top-tier entities demonstrate sustainable cash flow generation.
Return on Equity
Profit generated per dollar of shareholder equity
1.7%
Sector: 8.5%
Dividend Analysis audit
INCOME
2.38%
Trailing Yield
$2.38
Per $100 Invested
Solid dividend yield for income-focused strategies.
Est. Payout Ratio
375%HIGH
Analyst Projections
Analyst Consensus
Unlock Valuation Tools
Sign up for free access to institutional-quality research tools.
Based on our 6-factor quantitative model, American Healthcare REIT, Inc. (AHR) receives a "Hold" rating with a composite score of 52.2/100, ranked #605 out of 4446 stocks. Key factor scores: Quality 55/100, Value 58/100, Momentum 62/100. This is quantitative analysis only — not investment advice.
American Healthcare REIT, Inc. (AHR) Stock Analysis — April 2026 Rating, Price, and Forecast
Company Overview — What Does American Healthcare REIT, Inc. Do?
We are a self-managed REIT that acquires, owns and operates a diversified portfolio of clinical healthcare real estate properties, focusing primarily on MOBs, senior housing, SNFs, hospitals and other healthcare-related facilities. We have built a fully-integrated management platform, with 112 employees, that operates clinical healthcare properties throughout the United States, the United Kingdom and the Isle of Man. As of September 30, 2023, we had approximately $4.6 billion of total assets and were the ninth largest public reporting healthcare REIT (based on total assets). As of September 30, 2023, we owned and/or operated 298 buildings and integrated senior health campuses, representing an aggregate of approximately 18,875,000 square feet of GLA. Our long-standing track record of execution and expertise across multiple clinical healthcare asset classes is the foundation upon which we have built a strong, diversified portfolio of assets with a broad geographic footprint. Members of our management team have overseen the acquisition of approximately $9.6 billion in healthcare real estate investments (based on aggregate contract purchase price) over the last 17 years, on behalf of us and three other prior public reporting REITs. This long-standing track record of execution has allowed us to develop and foster deep operator, tenant and industry relationships, which we believe, in turn, have allowed us to access attractive investments and deliver favorable risk-adjusted returns. We believe that we are effectively positioned to grow over the near- and long-term through multiple operating segments, which include six reportable business segments—MOBs, integrated senior health campuses, SHOP, senior housing—leased, SNFs and hospitals. • MOBs. We value the stable and reliable cash flows our MOBs provide our portfolio, which we believe are particularly valuable during market disruptions and recessionary periods. As of September 30, 2023, we owned 90 MOBs that we lease to third parties, accounting for approximately 31.3% of our portfolio (based on aggregate contract purchase price on a pro rata share basis). These properties are similar to commercial office buildings, but typically require specialized infrastructure to accommodate physicians’ offices and examination rooms, as well as some ancillary uses, including pharmacies, hospital ancillary service space and outpatient services, such as diagnostic centers, rehabilitation clinics and outpatient-surgery operating rooms. As of September 30, 2023 and based on square feet on a pro rata share basis, approximately 75.0% of our MOBs were on-campus or adjacent to hospitals or Affiliated MOBs. Our MOBs are typically multi-tenant properties leased to healthcare providers (hospitals and physician practices) under leases that generally provide for recovery of certain operating expenses and certain capital expenditures and have initial terms of five to 10 years with fixed annual rent escalations (historically ranging from 2% to 3% per year). • Integrated Senior Health Campuses. Integrated senior health campuses are a valuable component of our portfolio because of their ability to provide a continuum of care as residents require increasing levels of care. As of September 30, 2023, we owned and/or operated 125 integrated senior health campuses, accounting for approximately 35.5% of our portfolio (based on aggregate contract purchase price on a pro rata share basis). These facilities allow residents to “age-in-place” by providing independent living, assisted living, memory care, skilled nursing and certain ancillary services, all within a single campus setting. Integrated senior health campuses predominantly focus on need-driven segments of senior care (i.e., assisted living, memory care and skilled nursing) and charge market rents in lieu of entry fees, as is commonly the case with continuing care retirement communities. Predominantly all of our integrated senior health campuses are operated utilizing a RIDEA structure, allowing us to participate in the upside from any improved operational performance while bearing the risk of any decline in operating performance. All of our integrated senior health campuses are held by Trilogy, one of our consolidated joint ventures in which we indirectly owned a 74.0% interest as of September 30, 2023, and are managed by a third-party operator, the Trilogy Manager. The management agreement between Trilogy and the Trilogy Manager limits the Trilogy Manager’s ability to compete with us and our portfolio and provides us exclusive rights to future opportunities identified by the Trilogy Manager, including future developments. • SHOP. Our SHOP segment has the potential for growth through the ongoing recovery from the COVID-19 pandemic and demand growth from an aging U.S. population. As of September 30, 2023, we owned and operated 46 senior housing facilities in our SHOP segment, accounting for approximately 17.9% of our portfolio (based on aggregate contract purchase price on a pro rata share basis). Senior housing facilities cater to different segments of the elderly population based upon their personal needs and include independent living, assisted living and memory care facilities. Residents of assisted living facilities typically require limited medical care but need assistance with eating, bathing, dressing and/or medication management. Services provided by operators at these facilities are primarily paid for by the residents directly or through private insurance and are therefore less reliant on government reimbursement programs, such as Medicaid and Medicare. The facilities in our SHOP segment are operated utilizing RIDEA structures, allowing us to participate in the upside from any improved operational performance while bearing the risk of any decline in operating performance. • Senior Housing—Leased. As of September 30, 2023, we owned 20 senior housing facilities that we lease to third parties within our senior housing—leased segment, accounting for approximately 4.4% of our portfolio (based on aggregate contract purchase price on a pro rata share basis). Each facility is leased to a single tenant under a triple-net lease structure with an initial term typically ranging from approximately 12 to 15 years, fixed annual rent escalations (historically ranging from 2% to 3% per year) and requiring minimum lease coverage ratios. We commonly structure senior housing—leased assets under a single master lease covering multiple facilities in order to diversify our master tenant’s sources of rent and mitigate risk. • SNFs. As of September 30, 2023, we owned 15 SNFs that we lease to third parties, accounting for approximately 5.5% of our portfolio (based on aggregate contract purchase price on a pro rata share basis). SNF residents are generally higher acuity and need assistance with eating, bathing, dressing and/or medication management and also require available 24-hour nursing care. SNFs offer restorative, rehabilitative and custodial nursing care for people who cannot live independently but do not require the more extensive and sophisticated treatment available at hospitals. Skilled nursing services provided by our tenants in SNFs are paid for either by private sources or through the Medicare and Medicaid programs. Each SNF is leased to a single tenant under a triple-net lease, with an initial term typically ranging from 12 to 15 years, fixed annual rent escalations (historically ranging from 2% to 3% per year) and requiring minimum lease coverage ratios. We commonly structure SNFs under a master lease with multiple facilities in order to diversify our master tenant’s sources of rent and mitigate risk. We typically focus on SNF investments in states that require a CON in order to develop new SNFs, which we believe reduces the risk of over-supply. • Hospitals. As of September 30, 2023, we had one wholly-owned hospital and one hospital in which we owned an approximately 90.6% interest, which together account for approximately 3.2% of our portfolio (based on aggregate contract purchase price on a pro rata share basis). Services provided by operators and tenants in our hospitals are paid for by private sources, third-party payors (e.g., insurance and health maintenance organizations) or through the Medicare and Medicaid programs. Our hospital properties include acute care, long-term acute care, specialty and rehabilitation services and are leased to single tenants or operators under triple-net lease structures. Our principal executive offices are located at 18191 Von Karman Avenue, Suite 300, Irvine, California. American Healthcare REIT, Inc. (AHR) is classified as a mid-cap stock in the Financials sector, specifically within the Trading industry. The company is led by CEO Danny Prosky, headquartered in IRVINE, California. With a market capitalization of $8.9B, AHR is one of the notable companies in the Financials sector.
American Healthcare REIT, Inc. (AHR) Stock Rating — Hold (April 2026)
As of April 2026, American Healthcare REIT, Inc. receives a Hold rating with a composite score of 52.2/100 and 3 out of 5 stars from the Blank Capital Research quantitative model.AHR ranks #605 out of 4,446 stocks in our coverage universe. Within the Financials sector, American Healthcare REIT, Inc. ranks #182 of 891 stocks, placing it in the top quartile of its Financials peers. The rating is generated by a multi-factor model that weighs quality (30%), momentum (25%), value (15%), investment (10%), stability (10%), and short interest (10%).
AHR Stock Price and 52-Week Range
American Healthcare REIT, Inc. (AHR) currently trades at $49.23. The stock gained $0.12 (0.2%) in the most recent trading session. The 52-week high for AHR is $54.67, which means the stock is currently trading -10.0% from its annual peak. The 52-week low is $26.48, putting the stock 85.9% above its annual trough. Recent trading volume was 2.5M shares, reflecting moderate market activity.
Is AHR Overvalued or Undervalued? — Valuation Analysis
American Healthcare REIT, Inc. (AHR) carries a value factor score of 58/100 in the Blank Capital model, indicating fair valuation relative to historical norms. The trailing price-to-earnings ratio is 157.61x, compared to the Financials sector average of 14.88x — a premium of 959%. The price-to-book ratio stands at 2.66x, versus the sector average of 1.22x. The price-to-sales ratio is 4.20x, compared to 0.90x for the average Financials stock. On an enterprise value basis, AHR trades at 15.60x EV/EBITDA, versus 3.26x for the sector.
Overall, AHR's valuation appears roughly in line with sector benchmarks, suggesting the market is pricing the stock fairly given its current fundamentals and growth trajectory. Neither deep value nor significantly overpriced, the stock occupies a middle ground on valuation.
American Healthcare REIT, Inc. Profitability — ROE, Margins, and Quality Score
American Healthcare REIT, Inc. (AHR) earns a quality factor score of 55/100, indicating solid business quality with consistent operational execution. The return on equity (ROE) is 1.7%, compared to the Financials sector average of 8.5%, which is below typical expectations for high-quality companies. Return on assets (ROA) comes in at 1.1% versus the sector average of 1.2%.
On a margin basis, American Healthcare REIT, Inc. reports gross margins of 18.7%. The operating margin is 18.7% (sector: 21.8%). Net profit margin stands at 2.5%, versus 17.7% for the average Financials stock. Revenue growth is running at 25.1% on a trailing basis, compared to 9.4% for the sector. The overall profitability profile is adequate, though there may be room for margin expansion.
AHR Debt, Balance Sheet, and Financial Health
American Healthcare REIT, Inc. has a debt-to-equity ratio of 61.0%, compared to the Financials sector average of 121.0%. Leverage is within a manageable range for the industry, though investors should monitor debt trends over time. The current ratio is 2.63x, indicating strong short-term liquidity. Cash and equivalents stand at $147M.
AHR has a beta of 0.81, meaning it is roughly in line with the broader market in terms of price volatility. The stability factor score for American Healthcare REIT, Inc. is 85/100, indicating low-volatility characteristics and consistent price behavior that appeals to risk-averse investors.
American Healthcare REIT, Inc. Revenue and Earnings History — Quarterly Trend
In TTM 2026, American Healthcare REIT, Inc. reported revenue of $2.13B and earnings per share (EPS) of $0.42. Net income for the quarter was $57M. Gross margin was 18.7%. Operating income came in at $397M.
In FY 2025, American Healthcare REIT, Inc. reported revenue of $2.26B and earnings per share (EPS) of $0.42. Net income for the quarter was $71M. Gross margin was 20.6%. Revenue grew 20.0% year-over-year compared to FY 2024. Operating income came in at $415M.
In Q3 2025, American Healthcare REIT, Inc. reported revenue of $573M and earnings per share (EPS) of $0.33. Net income for the quarter was $57M. Gross margin was 20.7%. Revenue grew 20.2% year-over-year compared to Q3 2024. Operating income came in at $106M.
In Q2 2025, American Healthcare REIT, Inc. reported revenue of $543M and earnings per share (EPS) of $0.06. Net income for the quarter was $10M. Gross margin was 21.4%. Revenue grew 18.4% year-over-year compared to Q2 2024. Operating income came in at $103M.
Over the past 8 quarters, American Healthcare REIT, Inc. has demonstrated a growth trajectory, with revenue expanding from $458M to $2.13B. Investors analyzing AHR stock should weigh these quarterly trends alongside the valuation and quality metrics discussed above.
AHR Dividend Yield and Income Analysis
American Healthcare REIT, Inc. (AHR) currently pays a dividend yield of 2.4%. At this yield, a $10,000 investment in AHR stock would generate approximately $$238.00 in annual dividend income. This compares to the Financials sector average dividend yield of 2.5%, meaning AHR yields less than the typical sector peer.
AHR Momentum and Technical Analysis Profile
American Healthcare REIT, Inc. (AHR) has a momentum factor score of 62/100, reflecting neutral trend characteristics. The stock is neither significantly outperforming nor underperforming the broader market on a momentum basis. The investment factor score is 25/100, which measures capital allocation efficiency and asset growth patterns. The short interest score of 5/100 signals elevated short interest, which can indicate bearish sentiment among institutional investors.
AHR vs Competitors — Financials Sector Ranking and Peer Comparison
Comparing AHR against the S&P 500 benchmark is also instructive for understanding relative performance. Investors can view the full AHR vs S&P 500 (SPY) comparison to assess how American Healthcare REIT, Inc. stacks up against the broader market across all factor dimensions.
AHR Next Earnings Date
No upcoming earnings date has been announced for American Healthcare REIT, Inc. (AHR) at this time. Check the earnings calendar for the latest scheduling updates across all stocks in our coverage universe.
Should You Buy AHR? — Investment Thesis Summary
American Healthcare REIT, Inc. presents a balanced picture with arguments on both sides. Price momentum is positive at 62/100, suggesting the trend favors buyers. Low volatility (stability score 85/100) reduces downside risk.
In summary, American Healthcare REIT, Inc. (AHR) earns a Hold rating with a composite score of 52.2/100 as of April 2026. The rating is derived from the Blank Capital Research methodology, which combines six factor dimensions into a single quantitative ranking. Investors should consider these quantitative signals alongside their own fundamental research, risk tolerance, and investment time horizon before making buy or sell decisions on AHR stock.
We'll email you when stocks you follow change their composite rating.
Institutional Research Dossier
American Healthcare REIT, Inc. (AHR) Deep Dive Analysis
Published on March 24, 2026
Action RatingHold
Sections
Executive Summary
We maintain a Hold rating on American Healthcare REIT (AHR). While the company's diversified portfolio of healthcare properties and experienced management team offer some stability, concerns about profitability, high valuation multiples, and a weak investment score warrant caution. The company's recent IPO and limited trading history further contribute to the uncertainty surrounding its long-term performance.
AHR operates in a defensive sector with favorable demographic tailwinds, but its high P/E ratio compared to the sector average and negative earnings in recent years raise questions about its current valuation. The company's reliance on RIDEA structures in its SHOP and integrated senior health campuses segments also exposes it to operational risks. While AHR's stability score is high, indicating lower volatility, its overall composite score suggests that investors should remain neutral until the company demonstrates consistent profitability and improved capital allocation.
Business Strategy & Overview
American Healthcare REIT (AHR) operates as a self-managed real estate investment trust (REIT) focused on acquiring, owning, and operating a diversified portfolio of clinical healthcare real estate. The company's strategy centers around investing in medical office buildings (MOBs), integrated senior health campuses, senior housing operating portfolio (SHOP), leased senior housing, skilled nursing facilities (SNFs), and hospitals. This diversification aims to provide a stable and reliable income stream, particularly during market disruptions and recessionary periods.
AHR's business model involves leasing its properties to healthcare providers, operators, and tenants under various lease structures, including triple-net leases and RIDEA structures. The company's integrated senior health campuses, primarily operated through its consolidated joint venture, Trilogy, offer a continuum of care, allowing residents to age in place. The SHOP segment, which includes senior housing facilities, caters to different segments of the elderly population and is less reliant on government reimbursement programs.
The company's strategic positioning involves focusing on need-driven segments of senior care and targeting states with Certificate of Need (CON) requirements for SNFs to reduce the risk of oversupply. AHR's management team has a long-standing track record of execution and expertise in healthcare real estate investments, which has allowed the company to develop strong relationships with operators, tenants, and industry players. This experience is expected to provide access to attractive investments and deliver favorable risk-adjusted returns.
AHR's growth strategy includes expanding its portfolio through acquisitions and developments in its core segments. The company aims to capitalize on the growing demand for healthcare services driven by an aging U.S. population and the ongoing recovery from the COVID-19 pandemic. The company's integrated management platform and diversified portfolio are expected to support its growth objectives over the near and long term.
Execution Benchmarks audit
Revenue Growth
YOY expansion rate
25.1%
Sector: 9.4%
+167% VS SCTR
Economic Moat Analysis
American Healthcare REIT's economic moat is likely Narrow. While the company benefits from some degree of competitive advantage, it is not strong enough to warrant a Wide moat rating. The healthcare REIT industry, in general, does not lend itself to wide moats due to the relatively low barriers to entry and the fragmented nature of the market.
One potential source of a narrow moat for AHR is its established relationships with operators and tenants. The company's management team has a long track record in the healthcare real estate sector, which has allowed them to develop strong relationships with key industry players. These relationships can provide AHR with access to attractive investment opportunities and favorable lease terms. However, these relationships are not exclusive and can be replicated by other REITs.
Another potential source of a narrow moat is the company's focus on states with Certificate of Need (CON) requirements for SNFs. CON regulations limit the supply of new SNFs, which can create a more favorable operating environment for existing facilities. However, CON regulations vary by state and are subject to change, which limits the durability of this advantage.
The company's diversified portfolio of healthcare properties also provides some degree of competitive advantage. By investing in multiple segments of the healthcare real estate market, AHR can reduce its exposure to any single segment and generate more stable cash flows. However, other REITs also have diversified portfolios, which limits the strength of this advantage.
Overall, AHR's economic moat is likely Narrow due to its established relationships, focus on CON states, and diversified portfolio. However, these advantages are not strong enough to warrant a Wide moat rating, as they are not exclusive and can be replicated by other REITs. The company's ability to maintain and expand its competitive advantages will depend on its ability to continue to develop strong relationships, identify attractive investment opportunities, and manage its portfolio effectively.
Financial Health & Profitability
American Healthcare REIT's financial health presents a mixed picture. The company's revenue has shown strong growth, with a 25.1% increase compared to the sector average of 9.3%. This growth is evident in the quarterly financial history, with revenue increasing from $1.64 billion in FY2022 to $2.26 billion in FY2025 (TTM). However, net income has been volatile, with negative figures in FY2022, FY2023, and FY2024, before turning positive in FY2025 (TTM). This inconsistency raises concerns about the company's profitability.
The company's gross margin and operating margin have also fluctuated. While the gross margin has generally remained above 12%, the operating margin has varied significantly, particularly in FY2023 and FY2022. The net margin is significantly lower than the sector average, indicating that the company is struggling to convert revenue into profit. The company's ROE is also significantly lower than the sector average, suggesting that it is not generating as much profit from shareholders' equity.
AHR's current ratio of 2.63 indicates strong liquidity, suggesting that the company has sufficient current assets to cover its current liabilities. The company's debt-to-equity ratio of 61.00 is lower than the sector average of 115.00, indicating that it is less leveraged than its peers. However, the absence of free cash flow data makes it difficult to assess the company's ability to generate cash from its operations.
Overall, AHR's financial health is characterized by strong revenue growth, but inconsistent profitability and lower margins compared to the sector average. The company's liquidity and leverage are relatively healthy, but the lack of free cash flow data and the volatile net income raise concerns about its long-term financial sustainability. Investors should closely monitor the company's ability to improve its profitability and generate consistent cash flow in the future.
Valuation Assessment
American Healthcare REIT's valuation appears stretched based on several key metrics. The company's P/E ratio of 114.6x is significantly higher than the sector average of 15.5x, suggesting that the stock is overvalued relative to its earnings. While the EV/EBITDA of 3.8x is slightly above the sector average of 3.5x, the disparity in P/E ratios raises concerns about the sustainability of the company's earnings and its ability to justify its current valuation.
The high P/E ratio may be partially attributed to the company's recent IPO and limited trading history, which can lead to inflated valuations. However, the company's negative earnings in recent years and inconsistent profitability also contribute to the high P/E ratio. Investors may be pricing in future growth and improved profitability, but there is no guarantee that the company will be able to meet these expectations.
The absence of free cash flow data makes it difficult to assess the company's valuation based on cash flow metrics. However, the company's volatile net income and lower margins compared to the sector average suggest that its free cash flow generation may also be inconsistent. This further supports the argument that the stock is overvalued.
Overall, American Healthcare REIT's valuation appears expensive relative to its growth, its history, and its sector. The high P/E ratio and inconsistent profitability raise concerns about the sustainability of the company's earnings and its ability to justify its current valuation. Investors should exercise caution and carefully consider the risks before investing in this stock.
Risk & Uncertainty
American Healthcare REIT faces several specific, idiosyncratic risks that could negatively impact its business and financial performance. One significant risk is the company's reliance on RIDEA structures in its SHOP and integrated senior health campuses segments. RIDEA structures expose the company to operational risks, as it participates in the upside and downside of the operating performance of these facilities. This means that the company's revenue and profitability are directly affected by the occupancy rates, operating expenses, and reimbursement rates of these facilities.
Another risk is the company's exposure to government reimbursement programs, such as Medicare and Medicaid, particularly in its SNF and hospital segments. Changes in government regulations or reimbursement rates could significantly impact the revenue and profitability of these facilities. The company's ability to adapt to these changes and maintain its occupancy rates will be critical to its long-term success.
The company also faces competition from other healthcare REITs and operators. The healthcare real estate market is fragmented, and AHR competes with a variety of players for investment opportunities and tenants. The company's ability to differentiate itself from its competitors and maintain its market share will be important to its growth and profitability.
Finally, the company's recent IPO and limited trading history create uncertainty about its long-term performance. The company's stock price may be volatile, and its ability to access capital markets in the future may be affected by its performance and market conditions. Investors should carefully consider these risks before investing in American Healthcare REIT.
Bulls Say / Bears Say
The Bull Case
BULL VIEWAmerican Healthcare REIT's diversified portfolio of healthcare properties provides a stable and reliable income stream, particularly during market disruptions.
BULL VIEWThe company's experienced management team has a long track record of execution and expertise in healthcare real estate investments, which will drive future growth.
BULL VIEWThe aging U.S. population and the growing demand for healthcare services will create favorable tailwinds for the company's SHOP and integrated senior health campuses segments.
The Bear Case
BEAR VIEWAmerican Healthcare REIT's high P/E ratio and inconsistent profitability suggest that the stock is overvalued and may not be able to sustain its current valuation.
BEAR VIEWThe company's reliance on RIDEA structures and government reimbursement programs exposes it to operational and regulatory risks that could negatively impact its financial performance.
BEAR VIEWThe fragmented nature of the healthcare real estate market and the company's recent IPO create uncertainty about its long-term growth and ability to compete effectively.
About the Author
Marques Blank
Founder & Chief Investment Officer, Blank Capital
Marques brings 15 years of institutional finance and investing experience, having overseen financial planning for a $1.6B defense business unit. He developed the proprietary 6-factor quantitative model used to score AHR and 4,400+ other equities.
American Healthcare REIT, Inc. exhibits a 456% valuation premium relative to institutional benchmarks. This represents a potential valuation overextension based on current multiples.
Return on Assets
Efficiency of asset utilization
1.1%
Sector: 1.2%
Gross Margin
Pricing power and cost efficiency
18.7%
Sector: 0.0%
Operating Margin
Core business profitability
18.7%
Sector: 21.8%
Net Margin
Bottom-line profitability
2.5%
Sector: 17.7%
Factor Methodology
The Quality factor evaluates the persistence and magnitude of cash flows. Companies with scores >70 exhibit superior competitive moats and financial resilience through economic cycles.
Sector Avg Yield2.48%
Yield Delta-4%
Income Projection audit
A $10,000 investment would generate approximately $238 annually in dividends at the current trailing rate.
